GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » C21 Investments Inc (OTCPK:CXXIF) » Definitions » COGS-to-Revenue

CXXIF (C21 Investments) COGS-to-Revenue : 0.54 (As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is C21 Investments COGS-to-Revenue?

C21 Investments's Cost of Goods Sold for the three months ended in Dec. 2024 was $4.27 Mil. Its Revenue for the three months ended in Dec. 2024 was $7.91 Mil.

C21 Investments's COGS to Revenue for the three months ended in Dec. 2024 was 0.54.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. C21 Investments's Gross Margin % for the three months ended in Dec. 2024 was 45.97%.


C21 Investments COGS-to-Revenue Historical Data

The historical data trend for C21 Investments's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C21 Investments COGS-to-Revenue Chart

C21 Investments Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.93 0.65 0.46 0.43 0.54

C21 Investments Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Jun24 Sep24 Dec24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.60 0.57 0.69 0.57 0.54

C21 Investments COGS-to-Revenue Calculation

C21 Investments's COGS to Revenue for the fiscal year that ended in Jan. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=15.487 / 28.888
=0.54

C21 Investments's COGS to Revenue for the quarter that ended in Dec. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=4.273 / 7.908
=0.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


C21 Investments  (OTCPK:CXXIF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

C21 Investments's Gross Margin % for the three months ended in Dec. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 4.273 / 7.908
=45.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


C21 Investments COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of C21 Investments's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


C21 Investments Business Description

Traded in Other Exchanges
Address
601 West Cordova Street, Suite 170, Vancouver, BC, CAN, V6B 1G1
C21 Investments Inc is a vertically integrated cannabis company that cultivates, processes, and distributes quality cannabis and hemp-derived consumer products in the United States. The Company owns Silver State Relief and Silver State Cultivation in Nevada, including legacy Oregon brands Phantom Farms, Hood Oil and Eco Firma Farms. These brands produce and distribute a broad range of THC and CBD products from cannabis flowers, pre-rolls, cannabis oil, vaporizer cartridges and edibles.

C21 Investments Headlines